A current method in gynecological cancer prediction: "Micronucleus": Review

Basit Öğe Kaydı
dc.contributor.authorEser, Ayla Açar
dc.contributor.authorGürbüz, Neslihan
dc.contributor.authorKaygusuz, İkbal Cekmen
dc.contributor.authorCanbal, Metin
dc.contributor.authorKoş???us, Aydin
dc.contributor.authorKöşüş, Nermin
dc.date.accessioned2025-10-24T18:06:47Z
dc.date.available2025-10-24T18:06:47Z
dc.date.issued2016
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractPrediction and early diagnosis of cancer are vital in gynecology. Studies have shown that both micronucleus (MN) and micronucleus tests (MNT)s can be used to predict cancers. Approximately 92% of all of the human malignancies occur in epithelial tissues. The MN assay in exfoliated cells is an innovative genotoxicity technique which holds promise for the study of epithelial carcinogens. Micronuclei are usually produced during the metaphase/anaphase transition of mitosis. If the process of cell division is disturbed, the sharing of the genetic material to the two daughter nuclei may be affected. The same situation will also occur if the chromosomes are broken or damaged by radiation, drugs and chemicals. Under these conditions, the genetic materials that are not included in the nuclei of the daughter cells will then form its own "micronucleus". A MNT is a special toxicological test that is usually employed in screening chemical compounds that are potentially genotoxic. The main objective of the test is to identify those genotoxic agents, which are capable of modifying the structure and segregation of chromosomes, in a specific way that enables the induction of micronuclei in interphase cells. MNT is used to determine carcinogenic agents that are capable of triggering off a specific type of cytogenetic damage, which lead to the formation of micronuclei containing lagging chromosome fragments or whole chromosomes. Recently MNT began to be used in gynecology and will be one of the most important parameter in prediction, prognoses and response to treatment of cancer in the near future. © 2018 Elsevier B.V., All rights reserved.
dc.identifier.doi10.5336/gynobstet.2014-41553
dc.identifier.endpage159
dc.identifier.issn1300-0306
dc.identifier.issn2146-9024
dc.identifier.issue3
dc.identifier.scopus2-s2.0-84994509659
dc.identifier.scopusqualityN/A
dc.identifier.startpage152
dc.identifier.trdizinid281966
dc.identifier.urihttps://doi.rog/10.5336/gynobstet.2014-41553
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/281966
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3210
dc.identifier.volume26
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherOrtadogŸu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret A.S. aysea@turkiyeklinikleri.com Turkocagi Caddesi No. 30 Balgat 06520
dc.relation.ispartofTurkiye Klinikleri Jinekoloji Obstetrik
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzScopus_20251023
dc.subjectEarly detection of cancer
dc.subjectMicronucleus tests
dc.subjectUterine cervical neoplasms
dc.titleA current method in gynecological cancer prediction: "Micronucleus": Review
dc.typeReview Article

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu